Cat. No. | Product Name | CAS No. | Purity | Chemical Structure |
---|---|---|---|---|
KM24248 | Belantamab | 2061894-48-0 | 96% | |
KM17079 |
Daratumumab
Daratumumab (Anti-Human CD38) 是首创的特异性抗 CD38 单克隆抗体。Daratumumab 具有抗多发性骨髓瘤(MM) 的作用。Daratumumab 损伤了 MM 细胞的粘附,从而增加了 MM 对蛋白酶体抑制的敏感性。 |
945721-28-8 | 98% | |
KP12687 | Datopotamab | 2267989-53-5 | ||
KM28500 | Enfortumab | 1448664-46-7 | 98% | |
KM23851 | Glembatumumab | 1020264-78-1 | ||
KM23882 | Inebilizumab | 1299440-37-1 | ||
KM22080 | Ozuriftamab | 2460399-44-2 | ||
KM31490 | Polatuzumab | 2279068-37-8 | 98% | |
KM31480 | Sacituzumab | 1796566-95-4 | 95% | |
KM17233 |
Trastuzumab
Trastuzumab 是一种人源化单克隆抗体,其以高亲和力与 HER2 选择性结合。Trastuzumab 可用于 HER2 阳性转移性乳腺癌和 HER2 阳性胃癌 的研究。 |
180288-69-1 | 98% |